Gene: MSS51
Official Full Name: MSS51 mitochondrial translational activatorprovided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30407 | MSS51 Knockout cell line (HeLa) | Human | MSS51 | 1:3~1:6 | Negative | Online Inquiry |
KO30408 | MSS51 Knockout cell line (HCT 116) | Human | MSS51 | 1:2~1:4 | Negative | Online Inquiry |
KO30409 | MSS51 Knockout cell line (HEK293) | Human | MSS51 | 1:3~1:6 | Negative | Online Inquiry |
MSS51 Gene Knockout Cell Lines are specialized cellular models engineered to lack the MSS51 gene, allowing researchers to study the gene's role in various biological processes and disease states. These knockout cell lines are generated through precise CRISPR/Cas9 technology, ensuring targeted and efficient gene disruption. By removing the MSS51 gene, scientists are able to investigate its involvement in metabolic pathways, cellular signaling, and potential contributions to disorders, thus providing invaluable insights into gene function and regulation.
The key mechanism of action hinges on the CRISPR/Cas9 gene-editing system, which creates double-strand breaks at specific genomic locations. Following this, cellular repair mechanisms attempt to repair the break, frequently resulting in insertions or deletions (indels) that disrupt the gene's function. MSS51 Gene Knockout Cell Lines enable researchers to elucidate complex pathways and interactions that are otherwise difficult to analyze, facilitating discoveries that may inform therapeutic strategies and drug development.
In research and clinical settings, these tools are crucial for elucidating gene function, testing drug efficacy, and exploring disease mechanisms. The insights garnered from MSS51 knockout studies can lead to breakthroughs in understanding diseases such as cancer, obesity, and metabolic syndrome, thereby advancing the field of molecular biology significantly.
Compared to other gene knockout alternatives, MSS51 Cell Lines provide enhanced specificity and reproducibility. The use of CRISPR technology allows for rapid development and validation, reducing the time needed to obtain results. Furthermore, our extensive validation ensures that these cell lines maintain robust characteristics across passages, making them reliable for experimental purposes.
For researchers and clinicians, the value of MSS51 Gene Knockout Cell Lines lies in their ability to provide a clearer understanding of genetic contributions to diseases, which can guide the development of more effective treatments. Our commitment to delivering high-quality biological products is backed by a team of experts whose deep understanding of molecular biology and genetics informs every aspect of our offerings. By integrating cutting-edge technology with rigorous validation processes, we empower our users to advance their research with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.